Stephen Mueller is the founder, Chief Executive Officer and technical visionary of Mile High Labs. After briefly working in electrical engineering, Steve saw the unique opportunity to capitalize on the CBD space. He’s been instrumental in the advancement of cannabinoid extraction, and his work has played a significant role in the creation of new technology, applications and processing methods.

Jon Hilley, Chief Financial Officer of Mile High Labs, leads the Company’s capital markets activities and financial reporting compliance. Jon began his career at Goldman Sachs before joining H.I.G. Capital as a buy-side research analyst where he learned the importance of per share value creation. This metric continues to serve as his guidelight and underpins every decision Mile High Labs makes.

Dr. Philip v. Mecklenburg joined Mile High Labs to create a world standard for CBD supply chains. As COO, he leads the Supply Chain Department and works with Marketing, Sales and IT teams to deliver first-class products to consumers. Philip has held a variety of executive roles in the logistics industry, both in Germany and the United States. Most recently, he was responsible for DB Schenker’s New York market and created the world’s largest Freight Marketplace.

Kate Mueller, Chief Product Officer of Mile High Labs, drives the company’s product roadmap, new product introductions and on-going portfolio management and optimization. With over a decade of experience bringing new products to market, Kate brings a track record of delivering innovative products at scale to meet global customer demand. Before joining Mile High Labs, she held various positions in product development and marketing at Fortune 500 companies.

Wendi Young, VP of Regulatory and Compliance, is advancing the Company’s cGMP compliance and certification efforts. Wendi spent 17 years in the pharmaceutical industry at Tolmar Inc. where she was involved in the development of over 25 products. She’s been involved in the implementation of FDA mandated changes, interpretation of new regulations and application of new controls. She also has participated in over 20 audits from various regulatory agencies.

Ryan Keeler oversees all manufacturing operations across the Mile High Labs network. He started his career as an intern at a Roche Pharmaceuticals site that became a contract manufacturing plant for Corden Pharmaceuticals. By the time he left, Keeler was Director of Operations for all manufacturing, maintenance and automation, and was in charge of managing over 170 employees. Today, he leads teams in our Broomfield facility as well as our flagship Loveland lab.